{"organizations": [], "uuid": "9581599df75968a0c4a60ffad274563101fafa31", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-alder-biopharmaceuticals-announces/brief-alder-biopharmaceuticals-announces-offering-of-200-mln-convertible-senior-notes-idUSASB0C2PD", "country": "US", "domain_rank": 408, "title": "BRIEF-Alder Biopharmaceuticals Announces Offering Of $200 Mln Convertible Senior Notes", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-29T14:16:00.000+02:00", "replies_count": 0, "uuid": "9581599df75968a0c4a60ffad274563101fafa31"}, "author": "", "url": "https://www.reuters.com/article/brief-alder-biopharmaceuticals-announces/brief-alder-biopharmaceuticals-announces-offering-of-200-mln-convertible-senior-notes-idUSASB0C2PD", "ord_in_thread": 0, "title": "BRIEF-Alder Biopharmaceuticals Announces Offering Of $200 Mln Convertible Senior Notes", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-alder biopharmaceuticals", "sentiment": "negative"}, {"name": "alder biopharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 29 (Reuters) - Alder Biopharmaceuticals Inc:\n* ALDER BIOPHARMACEUTICALS, INC. ANNOUNCES OFFERING OF $200 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2025\n* ALDER BIOPHARMACEUTICALS - INTENDS TO USE PROCEEDS FROM OFFERING TO FUND DEVELOPMENT, COMMERCIALIZATION OF EPTINEZUMAB Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-01-29T14:16:00.000+02:00", "crawled": "2018-01-29T14:30:47.005+02:00", "highlightTitle": ""}